Neurocrine Biosciences, Inc. (NBIX) Profit Margin
Neurocrine Biosciences, Inc. (NBIX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -940.60% |
| 2017-12-31 | -88.19% |
| 2018-12-31 | 4.68% |
| 2019-12-31 | 4.69% |
| 2020-12-31 | 38.94% |
| 2021-12-31 | 7.90% |
| 2022-12-31 | 10.38% |
| 2023-12-31 | 13.23% |
| 2024-12-31 | 14.49% |
| 2025-12-31 | 16.73% |
How NBIX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| A | Agilent Technologies Inc. | 18.75% |
| EW | Edwards Lifesciences Corporation | 17.69% |
| TMO | Thermo Fisher Scientific Inc | 15.05% |
| DHR | Danaher Corporation | 14.71% |
| BMY | Bristol-Myers Squibb Company | 14.64% |
These are five companies in the same sector as NBIX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Neurocrine Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("NBIX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NBIX | $150.82 | -3.62% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 |